Steven Cohen's JBIO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 167,204 shares of Jade Biosciences, Inc. (JBIO) worth $3.72 M, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in JBIO for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q1 2026, reducing 294,159 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Jade Biosciences (JBIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Jade Biosciences (JBIO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -97,111 | Reduce 36.74% | 167,204 | $22.22 |
| Q1 2026 | -294,159 | Reduce 52.67% | 264,315 | $14.05 |
| Q4 2025 | +558,474 | New Buy | 558,474 | $15.43 |
Steven Cohen's Jade Biosciences Investment FAQs
Steven Cohen first purchased Jade Biosciences, Inc. (JBIO) in Q4 2025, acquiring 558,474 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Jade Biosciences, Inc. (JBIO) for 3 quarters since Q4 2025.
Steven Cohen's largest addition to Jade Biosciences, Inc. (JBIO) was in Q4 2025, adding 558,474 shares worth $8.62 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 167,204 shares of Jade Biosciences, Inc. (JBIO), valued at approximately $3.72 M.
As of the Q2 2026 filing, Jade Biosciences, Inc. (JBIO) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Jade Biosciences, Inc. (JBIO) was 558,474 shares, as reported at the end of Q4 2025.